NDAINHALATIONGAS
Approved
Dec 2022
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
3/8 — Basic
XENOVIEW (xenon xe 129 hyperpolarized) by Polarean Imaging is magnetic resonance contrast activity [moa]. First approved in 2022.
Drug data last refreshed 17h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
XENOVIEW is a hyperpolarized xenon-129 gas inhaled as a magnetic resonance imaging contrast agent that enables visualization of pulmonary ventilation and gas exchange. It works through hyperpolarization technology to enhance MRI signal, allowing clinicians to assess lung function non-invasively. The drug represents a novel imaging modality for respiratory diagnostics.
Peak9.1 years to LOE
Early-stage specialty imaging product with minimal current market penetration; team size and hiring activity likely modest as market adoption remains limited.
Mechanism of Action
Magnetic Resonance Contrast Activity
Pharmacologic Class:
Hyperpolarized Contrast Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
XENOVIEW represents a specialized imaging career opportunity within an emerging hyperpolarized MRI space with limited current job market activity. Career growth will depend on market adoption acceleration and expansion into new respiratory indications over the nine-year patent window.
Field Specialist (Imaging)Medical Science Liaison
Worked on XENOVIEW at Polarean Imaging? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.